Researchers in China examined middle-aged male monkeys and found that those given a daily dose of metformin over three years ...

Metformin does not improve survival in unselected patients with metastatic hormone-sensitive prostate cancer (mHSPC), but the drug may improve survival and other outcomes in those with high-volume ...

After infection, prevalent metformin use is associated with a slightly lower incidence of mortality or long COVID.

A new study finds Metformin, a popular diabetes drug, may slow aging. WBZ-TV's Dr. Mallika Marshall reports. In this slot ...

After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, prevalent metformin use is associated with a slightly lower incidence of death or postacute sequalae of SARS-CoV-2 (PASC).

Dr. Crystal Aguh, a doctor at Johns Hopkins Medicine, is now using a diabetes medicine named metformin to combat hair loss in ...

The appellation “wonder drug” might even be an understatement, reckons Harvard Health’s Robert Shmerling, MD. But why?

The science of ageing is a captivating field. Researchers are exploring the roles of senescent cells, their signalling ...

Retta revealed that she was diagnosed with type 2 diabetes in July 2023, admitting that she “never thought” about the chronic ...

This is the first time Retta has spoken at length publicly about her diagnosis and she says she hopes that others are ...

Non-prescription anti-redness regimens are effective in reducing facial redness in patients with rosacea finds a study ...

The 13 drugs most likely to be chosen for CMS negotiations, according to the study: Ozempic, Rybelsus and Wegovy (semaglutide): Novo Nordisk's treatment for Type 2 diabetes and weight management.